Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

Research Institute

A study of Enfortumab Vedotin for urothelial cancer

A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer

Disease Types: Bladder

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer 

For more information:

https://clinicaltrials.gov/ct2/show/NCT03288545?term=NCT03288545&draw=2&rank=1